AVI should be be(have) spent $10 mil on Lobbying since the nov fiasco.
anything less when you are down to 1 drug and still 12 boys is inexcusable since the competition is using that against AVI everyday with the FDA + some major charities
2 + years 12 boys ridiculous
no more breaks till he closes this out
do you think prosensa or GSK don't have lobby firms working the fda
when christine/jenn/mindy and others walk the halls of congress they act as their own little firm
assume the slob does the same
and who the #$%$ k is going to know that?
he hired a lobby firm to do this #$%$
its called the heavy lifting
so far the ceo has gotten squat for his money
a big fat zero
and the fact the company is spending near 10 million a month now
i called the MDA this morning and i'm not even sure they are aware of the petition. i spoke to someone in media and they had no idea
another nice job by the lobbyist that CG hired to promote the company through the FDA process
CG you're still batting a 1000 on closing and looking strong to continue that streak
800 572 1717
Executive Vice President & Chief Medical and Scientific Officer
Dr. Valerie Cwik is the Executive Vice President & Chief Medical and Scientific Officer for the Muscular Dystrophy Association (MDA) where she oversees MDA’s extensive research and health care services programs and represents the Association at national and international scientific meetings.
Dr. Cwik has focused her career on neuromuscular diseases, beginning with fellowship training in EMG and neuromuscular diseases at the Cleveland Clinic in 1989 – 1990 under the mentorships of Dr. Asa Wilbourn and Dr. Hiroshi Mitsumoto. A second fellowship in neuromuscular diseases at the University of Alberta, under the mentorship of Dr. Michael Brooke, was followed by her appointment as Assistant Professor of Medicine (Neurology) at the same institution.
In 1996, Dr. Cwik relocated to Tucson, AZ, where she directed the Neuromuscular Disease Program in the Department of Neurology at the University of Arizona from 1996 through early 2004; she was director of the MDA/ALS Center there from 2001 through 2004.. Dr. Cwik has experience in clinical trials for Duchenne muscular dystrophy, ALS and diabetic peripheral neuropathy, and has mentored several neuromuscular fellows.